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Twelve single-nucleotide polymorphisms (SNPs) in the human g-aminobutyric acid type B (GABAB) receptor subunit
2 gene (GABAB2) were tested for association with nicotine dependence (ND) in an extensively phenotyped cohort
of 1,276 smokers and nonsmokers, representing ∼404 nuclear families of African American (AA) or European
American (EA) origin. The GABAB2 gene encodes a subunit of the GABAB receptor for GABA, an inhibitory
neurotransmitter involved in the regulation of many physiological and psychological processes in the brain. The
gene is located within a region of chromosome 9q22 that showed a “suggestive” linkage to ND. Individual SNP
analysis performed using the PBAT-GEE program indicated that two SNPs in the AAs and four SNPs in the EAs
were significantly associated with ND. Haplotype analysis using the Family-Based Association Test revealed that,
even after Bonferroni correction, the haplotype C-C-G of rs2491397-rs2184026-rs3750344 had a significant pos-
itive association with ND in both the pooled and the AA samples. In the EAs, we identified two haplotypes, C-A-
C-A and T-A-T-A, formed by SNPs rs1435252-rs378042-rs2779562-rs3750344, that showed a highly significant
negative and positive association with ND, respectively. In summary, our findings provide evidence of a significant
association of GABAB2 variants with ND, implying that this gene plays an important role in the etiology of this
drug addiction.
Tobacco use is a major worldwide health problem, and
nearly one-third of the global adult population smokes
tobacco products (United States Department of Health
and Human Services [USDHHS] 2000). Nicotine is the
primary reward component in tobacco that maintains
continued use and results in addiction (USDHHS 2000).
Nicotine dependence (ND [MIM 188890]), like many
other substance dependencies, is a complex trait deter-
mined by strong genetic and environmental factors (Sul-
livan and Kendler 1999; Li et al. 2003a). Our previous
meta-analysis of the genetic parameter for ND, which
was based on 17 reported twin studies, indicated an av-
erage weighted mean polygenic heritability of 0.56 for
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adult smokers (Li et al. 2003a). On the basis of the re-
sults from genomewide linkage analyses for smoking be-
havior, several chromosomal regions appear to harbor
susceptibility loci for ND (for recent reviews, see the
studies by Uhl et al. [2002] and Li et al. [2004]). How-
ever, no susceptibility genes for ND have yet been iden-
tified within these positive regions. In addition, although
numerous population-based association studies have
been conducted to examine the effects of functional can-
didate genes on ND, only a limited number of variants
have been confirmed in multiple cross-sectional studies
(Li et al. 2004).
We previously identified an ∼13-cM interval on chro-
mosome 9q22 that showed “suggestive” linkage with
ND (measured as the number of cigarettes smoked per
day, called “smoking quantity”) in the Framingham Heart
Study (FHS) samples (Li et al. 2003b). Furthermore, three
additional independent studies reported linkage—at a
nominally significant level—of smoking to a region on
chromosome 9 overlapping with our linked region (Ber-
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Table 1
Clinical Characteristics of the AA, EA, and Pooled Sample Groups
Characteristic AA EA Pooled
No. of families 253 151 404
Average no. of members/family (mean  SD) 3.1  .8 3.2  .7 3.2  .8
No. of subjects 793 483 1,276
% Female 64.6 68.7 66.1
Age (years) (mean  SD) 40.0  14.5 41.1  15.2 40.4  14.8
No. of smokers 622 468 990
Age at smoking onset (years) (mean  SD) 17.2  4.7 15.5  4.4 16.6  4.7
Years smoked (mean  SD) 21.0  12.7 24.1  12.8 22.1  12.8
SQ/day (mean  SD) 17.9  12.5 18.0  13.7 18.0  12.9
HSI score (mean  SD) 3.7  1.4 3.9  1.4 3.8  1.4
FTND score (mean  SD) 6.3  2.1 6.2  2.2 6.2  2.2
gen et al. 1999; Bierut et al. 2004; Gelernter et al. 2004).
The gene encoding the human g-aminobutyric acid
(GABA) type B receptor subunit 2 (GABAB2, also called
“G-protein–coupled receptor 51” [MIM 607340]) has
been mapped to the 9q22.1 region, spans ∼420,000,000
bp, and consists of a 3.1-kb coding region that is distrib-
uted over 19 exons (Martin et al. 2001). GABA is a major
neurotransmitter in the mammalian brain and controls
neuronal excitability. The GABAB receptor inhibits neu-
ronal activity through G-protein–coupled second-messen-
ger systems, which regulate the release of neurotransmit-
ters and the activity of ion channels and adenylyl cyclase
(Kaupmann et al. 1998). Two types of GABAB receptors
(GABAB1 and GABAB2) have been identified (Jones et al.
1998; Kaupmann et al. 1998). Although no unique phar-
macological or physiological roles have been determined
for either subtype of the GABAB receptor to date (Schuler
et al. 2001), studies in both humans and animals have
implicated GABAergic mechanisms in drug dependence,
including ND (Dewey et al. 1999; Corrigall et al. 2000).
Moreover, baclofen, a widely used GABAB agonist, is able
to antagonize nicotine-rewarding effects in mice and rats
(Fattore et al. 2002). Although there are lines of evidence
suggesting biological links between GABAB2 and smok-
ing behavior (Cousins et al. 2001; Fattore et al. 2002),
few genetic studies have examined the role of GABAB2
in the etiology of ND, and no polymorphism in the GA-
BAB2 gene has been reported to be associated with any
addictive behavior. On the other hand, association of the
a2 subunit of the GABAA receptor with alcohol depen-
dence has been reported (Edenberg et al. 2004). The link-
age results in the chromosomal 9q22 region, together with
a likely biological function of GABAB2 in drug addiction,
make this gene a plausible candidate for association with
ND.
The subjects used in this study were of either African
American (AA) or European American (EA) origin and
were recruited primarily from the mid-South states in
the United States from 1999 to 2004. The symptoms of
ND of probands and other smoker participants were as-
sessed with the Fagerstrom Test for Nicotine Dependence
(FTND) scale (Heatherton et al. 1991). Once a proband
was recruited, additional siblings and parents were re-
cruited whenever possible, regardless of smoking status.
Extensive clinical data were collected on all participants,
including demographics (e.g., sex, age, race, biological
relationships, weight, height, years of education, and
marital status), medical history, smoking history, smok-
ing experience, ND, and personality characteristics, as
assessed by various questionnaires (National Institute on
Drug Abuse, Center for Genetic Studies). Of the families
recruited, 75.7% (EAs: 74.2%; AAs: 76.7%) had at least
two siblings whose FTND score was 5 or above. All sub-
jects agreed to participate in this study and signed the
consent form, which was approved by each institutional
review board.
In the present study, the ND of each smoker was as-
certained by the three most commonly used measures in
the literature: smoking quantity (SQ) (also used in our
previous linkage study for ND in the FHS samples [Li
et al. 2003b]); the heaviness of smoking index (HSI [0–
6 scale]), which includes SQ and smoking urgency (i.e.,
how soon after waking up does the subject smoke the
first cigarette?); and the FTND score (0–10 scale). Given
the presence of overlap in the contents of the three ND
measures, there exist fairly robust correlations among
them ( ). The primary reason for runningrp 0.88–0.94
similar analyses for each of the three ND measures was
for comparison with previous findings. Demographic
and clinical characteristics are presented in table 1. DNA
from the participants was obtained using a blood ex-
traction kit from Qiagen. Selection of the SNPs for as-
sociation analysis was based on (1) a preference for SNPs
located in coding or regulatory regions of the gene, (2)
high heterozygosity (minor-allele frequency 0.15), and
(3) a uniform coverage of the gene. The 12 SNPs used
were selected from the dbSNP, JSNP, and Celera Genomics
databases. SNPs rs3750344 and rs2304389 are synony-
mous variants located in exons 2 and 15, respectively, of
GABAB2 (rs3750344 has an A/G transition at the third
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Table 2
P Values of PBAT-GEE Statistic for Significant Association ( ) for Individual GABAB2 SNPs with Three NDP ! .05
Measures
SNP ID
P VALUE(S) FOR SAMPLE GROUP AND ND MEASURE
Pooled AA EA
SQ HSI FTND SQ HSI FTND SQ HSI FTND
rs2304389 .01a,b .01a,b .03a,b .53 .74 .81 .07 .06 .14
rs1435252 .03a,b .10 .13 .07 .09 .09 .003a,b .009a,b .004a, .005b
rs3780422 .35 .28 .21 .43 .56 .49 .09 .08 .04a,b
rs1537959 .09 .03a,b .07 .02a,b .007a,b .02a,b .49 .40 .38
rs2491397 .03a,b .03a,b .07 .02a,b .04a,b .11 .17 .19 .12
rs2779562 .40 .29 .38 .78 .71 .44 .06 .01a,b,c .008c
rs3750344 .14 .30 .35 .33 .56 .74 .004c, .003a,b .03c, .02a,b .01c, .007a, .006b
NOTE.—Significant P values are shown in bold italics. The adjusted P value after correction for multiple testing
at the .05 significance level is .0043. For the pooled samples, the three ND measures were adjusted for age, sex, and
ethnicity; for each ethnic-specific sample group, only age and sex were used as covariates for the ND measures.
a Dominant model.
b Recessive model
c Additive model.
position of the 120th codon for alanine; rs2304389 has
a G/A transition at the third position of the 684th codon
for proline). The remaining 10 SNPs are located within
intronic regions of GABAB2. Data for these SNPs, in-
cluding their locations within the gene, chromosomal po-
sition, allele frequency, and primer/probe sequences, are
provided in table A1 (online only). SNPs were genotyped
using the TaqMan assay in a 384-well microplate format
(Applied Biosystems). Briefly, 15 ng of DNA was ampli-
fied in a total volume of 7 ml containing a minor groove
binder (MGB) probe and 2.5 ml of TaqMan Universal
PCR Master Mix. Amplification conditions were 2 min
at 50C and 10 min at 95C, followed by 40 cycles of
95C for 25 s and 60C for 1 min. Allelic discrimination
analysis was performed on the ABI Prism 9700 Sequence
Detection System. We applied the PedCheck program
(O’Connell and Weeks 1998) to identify any inconsistent
Mendelian inheritance, nonpaternity, or other typing er-
rors. To avoid bias, 135 inconsistencies (88 in the AA
samples and 47 in the EA samples) among ∼18,000 re-
actions for 12 SNPs were excluded from further statistical
analyses.
The pairwise FD′F values for the 12 selected SNPs with-
in GABAB2 were calculated using the GOLD program
(Abecasis and Cookson 2000) and showed a FD′F val-
ue of 10.72 for pairwise combinations of rs1547272,
rs1930139, and rs509747 in the AA, EA, and pooled
sample groups (see fig. A1 [online only]). In the AA sam-
ples, an additional SNP pair (rs1537959 and rs3780422)
showed a FD′F value of 10.72. These findings suggest that
the SNPs rs1547272-rs1930139-rs509747 and SNPs
rs1537959-rs3780422 are part of a single haplotype
block. We noticed differences for several SNPs, compared
with the allele frequencies presented on various SNP Web
sites, when we calculated the allele frequency by directly
counting the numbers of each allele from the progenitors
of our samples, especially in the AA samples (see table
A2 [online only]), suggesting an ethnicity-specific allele
distribution.
Association between a single SNP and three ND mea-
sures was determined by the Pedigree-Based Association
Test (PBAT) program with the use of generalized esti-
mating equations (Lange et al. 2003). Association be-
tween each ND measure and a haplotype was examined
using the Family-Based Association Test (FBAT) program,
with the option of computing P values of the Z statistic
with the use of Monte Carlo sampling under the null
distribution of no linkage and no association (Horvath et
al. 2004). Three genetic models (additive, dominant, and
recessive) were tested, with correction for sex and age in
the AA or EA samples and for sex, age, and ethnicity in
the pooled samples.
Analysis of individual SNPs indicated a significant as-
sociation for 4 of the 12 SNPs with at least one age-,
sex-, or ethnicity-adjusted ND measure in the pooled
samples (table 2). Given the potential genetic differences
in ND between ethnic groups, we analyzed all 12 SNPs
in the two ethnic groups separately. Two SNPs in the
AA samples and four SNPs in the EA samples showed
significant or highly significant association with at least
one ND measure under different genetic models. The
association of SNPs rs1435252 and rs3750344 in the
EA samples remained significant with the adjusted SQ
and FTND after correction for multiple testing, on the
basis of the SNP spectral decomposition approach (Ny-
holt 2004).
Haplotype analysis of SNPs rs2491397, rs2184026,
and rs3750344, which cover ∼135 kb of GABAB2, re-
vealed four major haplotypes (5%) in the AA samples
and five major haplotypes in the pooled and EA samples.
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In both the pooled and the AA samples, the C-C-G hap-
lotype of the three SNPs, with a frequency of 6.2% and
7.6%, respectively, showed a highly significant positive
association with the three adjusted ND measures (max
and permutation for associationZp 4.02 Pp .00001
with FTND in the pooled samples and max Zp 3.55
and permutation for association with FTNDPp .0004
in the AA samples, with 76 and 58 families contributing
to the associations, respectively) (see table 3). These re-
sults remained highly significant after Bonferroni cor-
rection for testing of the major haplotypes in each sam-
ple group. In the EA samples, we did not find a haplotype
for these three SNPs that remained significantly asso-
ciated with ND after Bonferroni correction.
Haplotype analysis of the rs1435252-rs3780422-
rs2779562-rs3750344 combination, which covers a re-
gion extending from exon 2 to intron 13 of GABAB2
(∼237 kb), revealed eight major haplotypes in the pooled
and AA samples and six major haplotypes in the EA sam-
ples. In the EA samples, the haplotype consisting of al-
leles C-A-C-A at a frequency of 12.8% showed a high-
ly significant inverse association, even after Bonferroni
correction, with all three adjusted ND measures (max
and permutation P p .0003 for HSI, withZp 3.40
33 families contributing to the analysis) (see table 3).
Additionally, in this EA sample group, we found another
haplotype (T-A-T-A) that was formed by the same four
SNPs at a frequency of 6.6% and that showed a signif-
icant association with the three adjusted ND measures;
however, this haplotype only remained significant for
FTND after Bonferroni correction (table 3). These find-
ings indicate haplotype specificities in the two ethnic
groups and further suggest different effects of haplotypes
within GABAB2 on ND in AAs and EAs.
Our study has several advantages. We chose to use the
single-marker PBAT program because it allows correc-
tion for covariates such as age, sex, and/or ethnicity. This
represents an important feature for our analysis, as age,
sex, and ethnic differences have been documented for
ND (Heath et al. 1999; Madden et al. 1999; Li et al.
2003a; Tyndale 2003). We used a family-based approach
for association analysis, which has an advantage over un-
conditional analyses (e.g., case-control analysis), in that
it minimizes the potential for the confounding effects of
population stratification. Furthermore, large samples of
smokers and nonsmokers from two ethnic groups were
analyzed, which allowed analysis of interethnic differ-
ences. Extensive phenotypic data on the individuals were
collected, which can be used to investigate different as-
pects of ND in future studies. The three ND measures
analyzed herein are commonly employed in the genetic
research and clinical settings of tobacco smoking and
thus would be readily available for cross-study repli-
cation. To our knowledge, this cohort represents one of
the largest family-based genetic samples designed spe-
cifically for studies of tobacco smoking.
We here provide the first evidence of an association
between the allelic variants of GABAB2 and ND. We
are aware that none of the GABAB2 SNPs included in
the current study represents an obvious causative vari-
ant. Only one significantly associated SNP (rs3750344)
is located within a coding region of GABAB2, but the
polymorphism does not result in an amino acid change.
Thus, no coding differences are present in any of the
GABAB2 SNPs from the higher-risk or protective hap-
lotypes. Because the associated SNPs are not necessar-
ily exclusive to GABAB2, a functional allelic variant(s)
close to or in strong linkage disequilibrium (LD) with
these SNPs may be responsible for ND vulnerability. We
therefore plan to analyze more SNPs within GABAB2,
as well as adjacent genes in this 13-cM region on chro-
mosome 9, not only because 9 of the 12 SNPs do not
show significant LD but also because of the data of the
haplotype analyses: the higher-risk haplotypes C-C-G and
T-A-T-A were found in 7.6% of the AA smokers and in
6.6% of the EA smokers, respectively, and the protective
haplotype C-A-C-A was found in 12.8% of the EA smok-
ers. This suggests that these haplotypes play an important
role in a relatively small proportion of smokers.
In summary, our association results provide evidence
of a significant impact of GABAB2 on ND—both for
individual SNPs and for multilocus haplotypes. We also
demonstrate that ethnic differences exist in the associ-
ation between GABAB2 and vulnerability to ND. This
study not only confirms molecular and pharmacological
data about the importance of the family of GABA re-
ceptor genes in addictive/behavioral traits but it also
provides new information on the genetics of ND, show-
ing the importance of the GABAB2 gene as a biological
candidate in future studies of ND.
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